JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 29 No. 7 1237-1245
© 1988 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vallabhajosula, S.
Right arrow Articles by Ginsberg, H. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vallabhajosula, S.
Right arrow Articles by Ginsberg, H. N.

Radiotracers for Low Density Lipoprotein Biodistribution Studies In Vivo: Technetium-99m Low Density Lipoprotein Versus Radioiodinated Low Density Lipoprotein Preparations

Shankar Vallabhajosula, Michael Paidi, Juan Jose Badimon, Ngoc-Anh Le, Stanley J. Goldsmith, Valentin Fuster and Henry N. Ginsberg

Mount Sinai School of Medicine, New York
College of Physicians and Surgeons, Columbia University, New York, New York

Correspondence: For reprints contact: Shankar Vallabhajosula, PhD, Andre Meyer Department of Physics-Nuclear Medicine, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, New York.

ABSTRACT

In an attempt to characterize the in vivo behavior of [99mTc] low density lipoprotein (LDL), biodistribution studies were performed in normal and hypercholesterolemic (HC) rabbits. In normal rabbits, 24 hr after the injection of [99mTc]LDL, 99mTc activity accumulated mainly in adrenal glands, spleen, liver, and kidney. In HC rabbits, however, there was a marked reduction of 99mTc activity in these organs. In both normal and HC rabbits, <17% of 99mTc activity appeared in the 24-hr urine following injection of [99mTc]LDL, suggesting that in vivo, [99mTc]LDL is trapped and accumulated within the tissues. Direct comparison of [99mTc]LDL, 125I-native-LDL and [131I]tyramine cellobiose-LDL (the previously validated trapped radioligand) in normal rabbits, demonstrated that the biodistribution of [99mTc]LDL was similar to that of [131I]tyramine cellobiose-LDL. The adrenal glands, liver, and spleen accumulated significantly greater quantities of 99mTc and 131I activity per gram of tissue than 125I (from native-LDL). In addition, imaging studies in monkeys, showed that the hepatic uptake and retention of [99mTc] LDL was similar to that of [131I]tyramine cellobiose LDL. In contrast, radioiodine from native-LDL was deiodinated in liver with subsequent excretion into the intestine. These results suggest that [99mTc]LDL acts as a trapped ligand in vivo and should therefore, be a good tracer for noninvasive quantitative biodistribution studies of LDL.




This article has been cited by other articles:


Home page
JNMHome page
S. Ben-Haim, E. Kupzov, A. Tamir, and O. Israel
Evaluation of 18F-FDG Uptake and Arterial Wall Calcifications Using 18F-FDG PET/CT
J. Nucl. Med., November 1, 2004; 45(11): 1816 - 1821.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. R. Davies, J. H. Rudd, and P. L. Weissberg
Molecular and Metabolic Imaging of Atherosclerosis
J. Nucl. Med., November 1, 2004; 45(11): 1898 - 1907.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. Awasthi, G. Meinken, K. Springer, S. C. Srivastava, and P. Freimuth
Biodistribution of Radioiodinated Adenovirus Fiber Protein Knob Domain after Intravenous Injection in Mice
J. Virol., June 15, 2004; 78(12): 6431 - 6438.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C.L. de Korte, S.G. Carlier, F. Mastik, M.M. Doyley, A.F.W. van der Steen, P.W. Serruys, and N. Bom
Morphological and mechanical information of coronary arteries obtained with intravascular elastography. Feasibility study in vivo
Eur. Heart J., March 1, 2002; 23(5): 405 - 413.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Z. A. Fayad and V. Fuster
Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque
Circ. Res., August 17, 2001; 89(4): 305 - 316.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Pasterkamp, E. Falk, H. Woutman, and C. Borst
Techniques characterizing the coronary atherosclerotic plaque: influence on clinical decision making?
J. Am. Coll. Cardiol., July 1, 2000; 36(1): 13 - 21.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Zuliani, M. Arca, A. Signore, G. Bader, S. Fazio, M. Chianelli, S. Bellosta, F. Campagna, A. Montali, M. Maioli, et al.
Characterization of a New Form of Inherited Hypercholesterolemia : Familial Recessive Hypercholesterolemia
Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 802 - 809.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Falk, P. K. Shah, and V. Fuster
Coronary Plaque Disruption
Circulation, August 1, 1995; 92(3): 657 - 671.
[Full Text]


Home page
ANN INTERN MEDHome page
S. Vallabhajosula, H. S. Gilbert, S. J. Goldsmith, M. Paidi, M. M. Hanna, and H. N. Ginsberg
Low-Density Lipoprotein e (LDL) Distribution Shown by 99mTechnetium-LDL Imaging in Patients with Myeloproliferative Diseases
Ann Intern Med, February 1, 1989; 110(3): 208 - 213.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1988 by the Society of Nuclear Medicine.